Effectiveness and Safety of Transcranial Laser Therapy for Acute Ischemic Stroke
Author(s) -
Justin A. Zivin,
Gregory W. Albers,
Natan M. Bornstein,
Thomas J. Chippendale,
Björn Dahlöf,
Thomas Devlin,
Marc Fisher,
Werner Hacke,
William L. Holt,
Sanja Ilic,
Scott E. Kasner,
Robert Lew,
Marshall Nash,
Julio E. Pérez,
Marilyn M. Rymer,
Peter D. Schellinger,
Dietmar Schneider,
Stefan Schwab,
Roland Veltkamp,
Michael G. Walker,
Jackson Streeter
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.109.547547
Subject(s) - medicine , stroke (engine) , ischemic stroke , acute stroke , transcranial doppler , cardiology , ischemia , tissue plasminogen activator , mechanical engineering , engineering
We hypothesized that transcranial laser therapy (TLT) can use near-infrared laser technology to treat acute ischemic stroke. The NeuroThera Effectiveness and Safety Trial-2 (NEST-2) tested the safety and efficacy of TLT in acute ischemic stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom